These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34736575)

  • 21. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone.
    Jondet M; Maroni M; Yaneva H; Brin S; Peltier-Pujol F; Pélissier C
    Maturitas; 2002 Feb; 41(2):115-21. PubMed ID: 11836042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.
    Davies GC; Huster WJ; Shen W; Mitlak B; Plouffe L; Shah A; Cohen FJ
    Menopause; 1999; 6(3):188-95. PubMed ID: 10486787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone.
    Mirkin S; Graham S; Revicki DA; Bender RH; Bernick B; Constantine GD
    Menopause; 2019 Jan; 26(6):637-642. PubMed ID: 30601452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
    Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
    Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause.
    Sriprasert I; Hodis HN; Karim R; Stanczyk FZ; Shoupe D; Henderson VW; Mack WJ
    J Clin Endocrinol Metab; 2019 Feb; 104(2):293-300. PubMed ID: 30272234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.
    Quaas AM; Kono N; Mack WJ; Hodis HN; Felix JC; Paulson RJ; Shoupe D
    Menopause; 2013 Aug; 20(8):840-4. PubMed ID: 23422867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence on the use of progesterone in menopausal hormone therapy.
    Mirkin S
    Climacteric; 2018 Aug; 21(4):346-354. PubMed ID: 29630427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study.
    Lewin A; Pisov G; Turgeman R; Fatum M; Shufaro Y; Simon A; Laufer N; Revel A; Reubinoff B; Safran A
    Gynecol Endocrinol; 2002 Apr; 16(2):131-6. PubMed ID: 12012623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study].
    Gillet JY; Faguer B; André G; Magnin G; de Lignières B; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):407-12. PubMed ID: 8051369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial.
    Murray MJ; Meyer WR; Lessey BA; Oi RH; DeWire RE; Fritz MA
    Menopause; 2003; 10(5):456-64. PubMed ID: 14501608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women.
    Elkind-Hirsch KE; Phillips K; Bello SM; McNicho M; de Ziegler D
    Hum Reprod; 2002 Feb; 17(2):295-8. PubMed ID: 11821266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
    Samsioe G; Boschitsch E; Concin H; De Geyter C; Ehrenborg A; Heikkinen J; Hobson R; Arguinzoniz M; Ibarra de Palacios P; Scheurer C; Schmidt G;
    Climacteric; 2006 Oct; 9(5):368-79. PubMed ID: 17080587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study.
    Pinto AB; Binder EF; Kohrt WM; Bronder DR; Williams DB
    Am J Obstet Gynecol; 2003 Jul; 189(1):11-5. PubMed ID: 12861131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.
    Henderson VW; St John JA; Hodis HN; McCleary CA; Stanczyk FZ; Shoupe D; Kono N; Dustin L; Allayee H; Mack WJ
    Neurology; 2016 Aug; 87(7):699-708. PubMed ID: 27421538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.